Page last updated: 2024-10-30

mimosine and von Hippel-Lindau Disease

mimosine has been researched along with von Hippel-Lindau Disease in 1 studies

Mimosine: 3-Hydroxy-4-oxo-1(4H)-pyridinealanine. An antineoplastic alanine-substituted pyridine derivative isolated from Leucena glauca.

von Hippel-Lindau Disease: An autosomal dominant disorder caused by mutations in a tumor suppressor gene. This syndrome is characterized by abnormal growth of small blood vessels leading to a host of neoplasms. They include HEMANGIOBLASTOMA in the RETINA; CEREBELLUM; and SPINAL CORD; PHEOCHROMOCYTOMA; pancreatic tumors; and renal cell carcinoma (see CARCINOMA, RENAL CELL). Common clinical signs include HYPERTENSION and neurological dysfunctions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khamaisi, M1
Toukan, H1
Axelrod, JH1
Rosenberger, C1
Skarzinski, G1
Shina, A1
Meidan, R1
Koesters, R1
Rosen, S1
Walkinshaw, G1
Mimura, I1
Nangaku, M1
Heyman, SN1

Other Studies

1 other study available for mimosine and von Hippel-Lindau Disease

ArticleYear
Endothelin-converting enzyme is a plausible target gene for hypoxia-inducible factor.
    Kidney international, 2015, Volume: 87, Issue:4

    Topics: Animals; Aspartic Acid Endopeptidases; Cell Hypoxia; Cells, Cultured; Cobalt; Dioxygenases; Endothel

2015